Colonial Trust’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-300
Closed -$30.5K 1148
2025
Q4
$30.5K Hold
300
﹤0.01% 618
2025
Q3
$16.4K Hold
300
﹤0.01% 696
2025
Q2
$15.9K Hold
300
﹤0.01% 707
2025
Q1
$13K Sell
300
-178
-37% -$9.01K ﹤0.01% 735
2024
Q4
$26.9K Buy
478
+178
+59% +$11.1K ﹤0.01% 726
2024
Q3
$20.4K Hold
300
﹤0.01% 709
2024
Q2
$12.7K Sell
300
-22
-7% -$1.21K ﹤0.01% 745
2024
Q1
$22.2K Buy
322
+2
+0.6% +$127 ﹤0.01% 640
2023
Q4
$23.7K Buy
320
+20
+7% +$1.31K ﹤0.01% 609
2023
Q3
$20.5K Hold
300
0.01% 602
2023
Q2
$28.2K Hold
300
0.01% 554
2023
Q1
$20.3K Hold
300
0.01% 581
2022
Q4
$14.9K Buy
+300
New +$12.3K ﹤0.01% 616

Other funds holding EXAS

Colonial Trust's EXAS Position: Q1 2026 in Review

Colonial Trust sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 300 shares — an estimated $30.5K sold.

Colonial Trust first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $30.5K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Colonial Trust reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Colonial Trust sold 300 Exact Sciences shares in Q1 2026, an estimated $30.5K.
  • Colonial Trust first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Colonial Trust's Exact Sciences position peaked at $30.5K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Colonial Trust's 13F filing for Q1 2026, filed 12 May 2026.